FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -149,483.3% | -111,116.7% | – | – | -26,339.5% | – | – | – | – | – | – | – | |
| – | 100.0% | 150.0% | – | – | 26.3% | – | – | – | – | – | – | – | |
| – | 13,000.0% | 13,416.7% | – | – | 1,834.2% | – | – | – | – | – | – | – | |
| – | -64,850.0% | -916.7% | – | – | -8,960.5% | – | – | – | – | – | – | – | |
| – | 283.3% | 100.0% | – | – | 81.6% | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | -94,702.6% | – | – | – | – | – | – | – | |
| – | -1.3% | -266.7% | – | – | -5.3% | – | – | – | – | – | – | – | |
| – | -1,250.0% | -133.3% | – | – | 136,518.4% | – | – | – | – | – | – | – | |
| – | -153,050.0% | -22,100.0% | – | – | 15,476.3% | – | – | – | – | – | – | – | |
| – | -149,766.7% | -111,216.7% | – | – | -26,421.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.